Additionally, HIF-1α and HIF-2α drive angiogenesis during tumour development [47], whereas HIF-3α negatively regulates the HIF pathway in vascular cells by decreasing hypoxia-mediated VEGF expression [48]. The gene discussed is EPAS1; the disease is neoplasm.